Topics

Food and Drug Administration
U.S. doctor was treated with experimental Ebola drug TKM-Ebola
U.S. doctor was treated with experimental Ebola drug TKM-Ebola

An American doctor who is recovering from Ebola at a Nebraska hospital got an experimental Canadian drug as part of his treatment, hospital officials disclosed this week. Dr. Rick Sacra started receiving TKM-Ebola, manufactured by Canadian drug firm Tekmira, on Sept. 5, the day he arrived at Nebraska Medical Center in Omaha, hospital officials said in a statement. The drug, which is designed to stop the Ebola virus from replicating, was administered to Sacra over seven days.  Sacra had also received blood plasma transfusions from Dr. Kent Brantly, a fellow missionary who has recovered from the disease and was discharged from Emory University Hospital last month. The...

Loading